Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$923K Buy
2,547
+30
+1% +$10.3K 0.13% 168
2026
Q1
$885K Buy
2,517
+90
+4% +$32.1K 0.14% 163
2025
Q4
$830K Buy
2,427
+145
+6% +$46K 0.13% 170
2025
Q3
$644K Buy
2,282
+53
+2% +$15.4K 0.11% 191
2025
Q2
$657K Sell
2,229
-44
-2% -$12.5K 0.11% 175
2025
Q1
$645K Buy
2,273
+407
+22% +$120K 0.13% 164
2024
Q4
$487K Sell
1,866
-9
-0.5% -$2.67K 0.11% 182
2024
Q3
$604K Buy
1,875
+12
+0.6% +$3.92K 0.14% 147
2024
Q2
$579K Buy
1,863
+10
+0.5% +$2.94K 0.14% 145
2024
Q1
$524K Buy
1,853
+37
+2% +$10.8K 0.15% 148
2023
Q4
$540K Sell
1,816
-25
-1% -$6.81K 0.16% 144
2023
Q3
$488K Buy
1,841
+88
+5% +$22K 0.15% 159
2023
Q2
$383K Buy
1,753
+55
+3% +$12.8K 0.15% 153
2023
Q1
$426K Sell
1,698
-105
-6% -$25.8K 0.18% 147
2022
Q4
$457K Buy
1,803
+574
+47% +$154K 0.19% 138
2022
Q3
$283K Buy
1,229
+110
+10% +$26.7K 0.23% 131
2022
Q2
$276K Buy
1,119
+170
+18% +$41.7K 0.23% 125
2022
Q1
$237K Buy
+949
New +$218K 0.16% 165

Other funds holding AMGN

Ignite Planners's AMGN Position: Q2 2026 in Review

Ignite Planners increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $10.3K and bringing the position to 2,547 shares worth $923K. The position accounts for 0.13% of the portfolio, ranked #168.

Ignite Planners first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. 1,474 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ignite Planners held 2,547 shares of Amgen worth $923K as of Q2 2026.
  • Ignite Planners bought 30 Amgen shares in Q2 2026, an estimated $10.3K.
  • Amgen made up 0.13% of Ignite Planners's portfolio in Q2 2026, its #168 holding.
  • Ignite Planners first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
  • 1,474 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.